Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as yet unknown mechanism. Recently, a working mechanism for apoE was proposed (Twisk, J., Gillian-Daniel, D. L., Tebon, A., Wang, L., Barrett, P. H., and Attie, A. D. (2000) J. Clan. Invest. 105, 521-532) in which apoE prevents the inhibitory action of the low density lipoprotein receptor (LDLr) by binding to it. We have first tested whether this newly described effect of the LDLr on VLDL secretion, obtained in vitro, is also observed in vavo. In LDLr knockout mice (LDLr-/-), the production of VLDL triglycerides and apoB was 30% higher than that in controls. Also the ratio of apoB100:apoB48 secretion was increased in the LDLr-/- mice. The composit...
Objective—To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding r...
Apo E is a key molecule in the lipoprotein metabolism; thus, genetic manipulation of apo E may prove...
To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding region, on ...
Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as ye...
Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as ye...
Abstract—The low density lipoprotein (LDL) receptor is well known for its role in mediating the remo...
To investigate the quantitative requirement for apolipoprotein (apo) E in the clearance of lipoprote...
ApoE-deficient mice on low fat diet show hepatic triglyceride accumulation and a reduced very low de...
To investigate the relative roles of the LDL receptor- and non-LDL receptor-mediated pathways in the...
In humans, apolipoprotein (apo) E4 is associated with elevated plasma cholesterol levels and a high ...
Apolipoprotein E (apoE) is hypothesized to mediate lipoprotein clearance by binding to two receptors...
To explore mechanisms underlying triglyceride (TG) accumulation in livers of chow-fed apo E-deficien...
AbstractThe VLDL receptor, a newly identified lipoprotein receptor, recognizes apoE containing lipop...
We have investigated the interaction of apolipoprotein E2(Arg158- Cys) (apoE2) and apolipoprotein E3...
Apolipoprotein E (apoE)-deficient mice develop hepatic steaatosis and show impaired very low density...
Objective—To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding r...
Apo E is a key molecule in the lipoprotein metabolism; thus, genetic manipulation of apo E may prove...
To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding region, on ...
Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as ye...
Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as ye...
Abstract—The low density lipoprotein (LDL) receptor is well known for its role in mediating the remo...
To investigate the quantitative requirement for apolipoprotein (apo) E in the clearance of lipoprote...
ApoE-deficient mice on low fat diet show hepatic triglyceride accumulation and a reduced very low de...
To investigate the relative roles of the LDL receptor- and non-LDL receptor-mediated pathways in the...
In humans, apolipoprotein (apo) E4 is associated with elevated plasma cholesterol levels and a high ...
Apolipoprotein E (apoE) is hypothesized to mediate lipoprotein clearance by binding to two receptors...
To explore mechanisms underlying triglyceride (TG) accumulation in livers of chow-fed apo E-deficien...
AbstractThe VLDL receptor, a newly identified lipoprotein receptor, recognizes apoE containing lipop...
We have investigated the interaction of apolipoprotein E2(Arg158- Cys) (apoE2) and apolipoprotein E3...
Apolipoprotein E (apoE)-deficient mice develop hepatic steaatosis and show impaired very low density...
Objective—To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding r...
Apo E is a key molecule in the lipoprotein metabolism; thus, genetic manipulation of apo E may prove...
To examine the effects of apoB100 structure, specifically a mutation in the LDLr binding region, on ...